Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2013

View Archived Issues

Ghrelin agonist tested in gastrointestinal symptoms related to Parkinson's disease

Global molecular signature for the prognosis of hepatocellular carcinoma identified

[11C]Cimbi-36 demonstrates utility for human brain imaging

Development of Sangamo BioSciences' ZFP beta-thalassemia treatment receives support

Novel pneumonia vaccine candidate induces systemic and mucosal immune response in vivo

In vivo results for a novel ApoC-II mimetic peptide reported

Oxford BioMedica develops a novel gene therapy for IOP

A novel PET tracer shows PDE10A specificity in rat and monkey striatum

Astellas Pharma will not seek European approval for tivozanib in RCC

Valeant Pharmaceuticals to acquire Bausch & Lomb

GSK and Tempero Pharmaceuticals jointly develop HDAC9 inhibitors

Recent Merck & Co. patents describe novel ROMK blockers

Novel nicotinic alpha4beta2 receptor ligands identified by Targacept

Italian researchers synthesize novel HSP 90 inhibitors

Vertex Pharmaceuticals discloses novel Na(v)1.7 blockers

Virobay begins phase I trial of oral pain treatment candidate VBY-036

PlantForm and PharmaPraxis collaborate on biosimilars/biobetters

Astellas' isavuconazole granted orphan drug status for invasive aspergillosis

Chembio awarded U.S. government contract to develop diagnostic tests

Eisai set to launch Inovelon tablets in Japan

4SC's Japanese partner Yakult Honsha begins phase I/II study of resminostat in liver cancer

Bayer's Xarelto approved in Europe for additional indication

AstraZeneca enters definitive agreement to acquire Omthera Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...